Today's Daily Dose brings you news about Atossa's near-term catalyst; Acer's progress in vascular Ehlers-Danlos syndrome trial; Eiger's phase II PREVENT study, and Mustang Bio's deal with St. Jude Children's Research Hospital for bubble boy gene therapy.
from RTT - Biotech https://ift.tt/2MjKTBT
via IFTTT
No comments:
Post a Comment